Published Online
on July 12, 2004

A more recent version of this article appeared on July 27, 2004

This Article Full Text (PDF) All Versions of this Article: 110/4/374    most recent 01.CIR.0000136580.34604.B8v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sawhney, N. Articles by Teirstein, P. S. Search for Related Content PubMed PubMed Citation Articles by Sawhney, N. Articles by Teirstein, P. S. Related Collections Restenosis Catheter-based coronary interventions: stents Angioplasty and Stenting

Submitted on February 6, 2004
Revised on May 6, 2004
Accepted on May 10, 2004

Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents

Neil Sawhney MD, Jeffrey W. Moses MD, Martin B. Leon MD, Richard E. Kuntz MD, Jeffrey J. Popma MD, William Bachinsky MD, Theodore Bass MD, Samuel DeMaio MD, Edward Fry MD, David R. Holmes Jr MD, and Paul S. Teirstein MD^*

From the Division of Cardiology, Scripps Clinic, San Diego, Calif (N.S., P.S.T.); the Cardiovascular Research Foundation, New York, NY (J.W.M., M.B.L.); Harvard Clinical Research Institute, Boston, Mass (R.E.K.); Brigham and Women’s, Boston, Mass (J.J.P.); Harrisburg Hospital, Harrisburg, Pa (W.B.); the University of Florida, Jacksonville (T.B.); Seton Medical Center, Austin, Tex (S.D.); St Vincent’s Hospital, Indianapolis, Ind (E.F.); and the Mayo Clinic, Rochester, Minn (D.R.H.).

^* To whom correspondence should be addressed. E-mail: pteirstein{at}scrippsclinic.com.

Background--Revascularization strategies often hinge on the presence and degree of left anterior descending coronary artery (LAD) stenosis. A decision for bypass surgery is often based on the durability of surgical LAD revascularization compared with percutaneous approaches. By decreasing restenosis, drug-eluting stents may have reduced the "reintervention gap" between surgery and percutaneous intervention, making the percutaneous route preferable.

Methods and Results--Of the 1101 patients in the SIRIUS trial, 459 with an LAD stenosis were randomized to percutaneous intervention with either sirolimus-eluting or bare-metal stents. Baseline demographic, clinical, and angiographic data were obtained. Patients had 1-year clinical and 8-month angiographic follow-up. Baseline characteristics were similar in both groups. The majority of lesions were tubular type B lesions (69.7%) with a mean diameter of 2.73 mm and a mean length of 14.0 mm. The binary in-stent restenosis rate was 2% for the sirolimus stent group and 41.6% for the bare-metal arm (relative risk, 0.05; 95% CI, 0.02 to 0.1; P<0.001). One-year major adverse events (defined as cardiac death, Q-wave and non-Q-wave myocardial infarction, or target vessel revascularization) was decreased 59% in the sirolimus-stent group (9.8% versus 24.9%; relative risk, 0.39; 95% CI, 0.26 to 0.61; P<0.001). Subgroup analysis of 135 patients with proximal LAD lesions showed similar benefits. In-stent restenosis was 0 in the proximal LAD sirolimus-eluting group (n=67), compared with 38% in the bare-metal arm (n=68), and major adverse events demonstrated a similar trend, with a 50% decrease compared with control patients (10.4% versus 20.6%, P=NS).

Conclusions--Sirolimus-eluting stents significantly decrease revascularization rates in LAD lesions. At 1 year, sirolimus-eluting stent revascularization rates are comparable to historic single vessel bypass surgery revascularization rates.

Key words: angioplasty • stents • cardiovascular disease

This article has been cited by other articles:

				H. Thiele, P. Neumann-Schniedewind, S. Jacobs, E. Boudriot, T. Walther, F.-W. Mohr, G. Schuler, and V. Falk Randomized Comparison of Minimally Invasive Direct Coronary Artery Bypass Surgery Versus Sirolimus-Eluting Stenting in Isolated Proximal Left Anterior Descending Coronary Artery Stenosis J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2324 - 2331. [Abstract] [Full Text] [PDF]

				J. G. Byrne, M. Leacche, D. E. Vaughan, and D. X. Zhao Hybrid Cardiovascular Procedures J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 459 - 468. [Abstract] [Full Text] [PDF]

				Y. Ben-Gal, R. Mohr, R. Braunstein, A. Finkelstein, N. Hansson, A. Hendler, Y. Moshkovitz, and G. Uretzky Revascularization of Left Anterior Descending Artery With Drug-Eluting Stents: Comparison With Minimally Invasive Direct Coronary Artery Bypass Surgery Ann. Thorac. Surg., December 1, 2006; 82(6): 2067 - 2071. [Abstract] [Full Text] [PDF]

				H. B. Barner Status of percutaneous coronary intervention and coronary artery bypass. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 419 - 424. [Abstract] [Full Text] [PDF]

				I. Herz, Y. Moshkovitz, D. Loberman, G. Uretzky, R. Braunstein, A. Hendler, E. Zivi, Y. Ben-Gal, and R. Mohr Drug-Eluting Stents Versus Bilateral Internal Thoracic Grafting for Multivessel Coronary Disease Ann. Thorac. Surg., December 1, 2005; 80(6): 2086 - 2090. [Abstract] [Full Text] [PDF]

				H. Thiele, S. Oettel, S. Jacobs, R. Hambrecht, P. Sick, J. F. Gummert, F. W. Mohr, G. Schuler, and V. Falk Comparison of Bare-Metal Stenting With Minimally Invasive Bypass Surgery for Stenosis of the Left Anterior Descending Coronary Artery: A 5-Year Follow-Up Circulation, November 29, 2005; 112(22): 3445 - 3450. [Abstract] [Full Text] [PDF]

				J. S. Douglas Jr, D. R. Holmes Jr, D. J. Kereiakes, C. L. Grines, E. Block, Z. M.B. Ghazzal, D. C. Morris, H. Liberman, K. Parker, C. Jurkovitz, et al. Coronary Stent Restenosis in Patients Treated With Cilostazol Circulation, November 1, 2005; 112(18): 2826 - 2832. [Abstract] [Full Text] [PDF]

				Y. Moshkovitz, R. Mohr, R. Braunstein, E. Zivi, G. Uretzky, Y. Ben-Gal, and I. Herz Revascularization of Left Anterior Descending Coronary Artery in Patients With Single and Multivessel Disease: Comparison Between Off-Pump Internal Thoracic Artery and Drug-Eluting Stent Chest, August 1, 2005; 128(2): 804 - 809. [Abstract] [Full Text] [PDF]

				E. Tsagalou, A. Chieffo, I. Iakovou, L. Ge, G. M. Sangiorgi, N. Corvaja, F. Airoldi, M. Montorfano, I. Michev, and A. Colombo Multiple Overlapping Drug-Eluting Stents to Treat Diffuse Disease of the Left Anterior Descending Coronary Artery J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1570 - 1573. [Abstract] [Full Text] [PDF]

				D. J. Drenth, F. Zijlstra, P. W. Boonstra, N. Sawhney, P. S. Teirstein, J. W. Moses, M. B. Leon, R. E. Kuntz, J. J. Popma, W. Bachinsky, et al. Letter Regarding Article by Sawhney et al, "Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents" * Response Circulation, April 26, 2005; 111(16): e265 - e266. [Full Text] [PDF]

				D. J. Kereiakes, R. E. Kuntz, L. Mauri, and M. W. Krucoff Surrogates, substudies, and real clinical end points in trials of drug-eluting stents J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1206 - 1212. [Full Text] [PDF]

				W. W. O'Neill, S. R. Dixon, and C. L. Grines The year in interventional cardiology J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1117 - 1134. [Full Text] [PDF]

				Authors/Task Force Members, S. Silber, P. Albertsson, F. F. Aviles, P. G. Camici, A. Colombo, C. Hamm, E. Jorgensen, J. Marco, J.-E. Nordrehaug, et al. Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Eur. Heart J., April 2, 2005; 26(8): 804 - 847. [Full Text] [PDF]